Pfizer’s CEO, a former veterinarian, used a high-risk strategy to make vaccine history

Pfizer’s CEO, a former veterinarian, used a high-risk strategy to make vaccine history

Pfizer CEO Albert Bourla isn’t afraid of taking risks — and it’s paid off in big ways for the pharmaceutical and biotech giant.

When Bourla took over as Pfizer’s leader in 2019, he took a high-risk, high reward approach by betting heavily on cutting-edge science and the customer experience.

His strategy is paying off. After 16 years, Pfizer rejoined Fortune’s list of the Most Admired Companies, largely because of Bourla’s vision and the company’s historic COVID vaccine launch.